Gyros announces changes to its management team
Dr. Jon-Sverre Schanche becomes Chief Technology Officer and Vice President Technical Affairs
Gyros AB announced the appointment of Dr. Jon-Sverre Schanche as Chief Technology Officer and Vice President Technical Affairs. Dr. Schanche’s appointment comes as Nils Kristensen, COO and VP Technical Operations, and Stephan Hoffmann, VP Business Development, leave the company.
Dr. Schanche has almost thirty years of industrial R&D and management experience. In his new role he will hold responsibility for business and product development as well as production and manufacturing. Most recently, Dr. Schanche was Vice President R&D at DAKO Denmark A/S where he established a system development organization for in vitro diagnostic products. Before this, he held executive roles within the drug discovery and biotechnology supply industry, including Vice President of R&D in Personal Chemistry AB and Biotage AB and several senior management positions in Amersham Pharmacia Biotech (now GE Healthcare), including General Manager for the Norwegian R&D site.
Other news from the department people
Most read news
Last viewed contents
Wyeth Extends Agreement with Affymetrix to 15 Years
New clinical study aims to prevent type 1 diabetes in children
First genetic link to common migraine exposed - Genetic variant may increase susceptibility to migraine triggers
Affibody and Agilent Technologies to Develop Robust Protein Sample
UCB and Proteros expand successful protein x-ray crystallography collaboration - Collaboration aims to accelerate drug discovery for new therapies in central nervous system (CNS) disorders and immunology diseases
Biological risk potential of nanoparticles studied
Irukandji_syndrome
